Randall D. Marshall

Technik-/Wissenschafts-/F&E-Leiter bei Eumentis Therapeutics, Inc.

Consumer Services

Commercial Services

Health Technology

Profil

Randall D.
Marshall is currently the Director & Chief Medical Officer at Eumentis Therapeutics, Inc. Previously, he worked as the Executive Director-Medical Affairs at Euthymics Bioscience, Inc. Marshall received his undergraduate degree from Rice University and his doctorate from The Johns Hopkins University.

Aktive Positionen von Randall D. Marshall

Unternehmen	Position	Beginn
Eumentis Therapeutics, Inc. Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation.	Technik-/Wissenschafts-/F&E-Leiter	-

Alle aktiven Positionen von Randall D. Marshall

Ehemalige bekannte Positionen von Randall D. Marshall

Unternehmen	Position	Ende
Euthymics Bioscience, Inc. Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Randall D. Marshall im Detail an

Ausbildung von Randall D. Marshall

The Johns Hopkins University	Doctorate Degree
Rice University	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Randall D. Marshall im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Euthymics Bioscience, Inc. Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA.	Commercial Services
Eumentis Therapeutics, Inc. Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation.	Health Technology